𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HLA-A2 expression, stage, and survival in colorectal cancer

✍ Scribed by Philipp Kiewe; Veit Mansmann; Carmen Scheibenbogen; Heinz-Johannes Buhr; Eckhard Thiel; Dirk Nagorsen

Book ID
106059550
Publisher
Springer
Year
2008
Tongue
English
Weight
142 KB
Volume
23
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Misclassification of colorectal cancer s
Misclassification of colorectal cancer stage and area variation in survival
✍ Xue Q. Yu; Dianne L. O'Connell; Robert W. Gibberd; Michal Abrahamowicz; Bruce K. πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 95 KB

## Abstract We previously investigated the impact of health area of residence on colon and rectal cancer survival by estimating area‐specific relative excess risk of death (RER), stratified by stage at diagnosis. The aims of this study were to quantify errors in colorectal cancer stage obtained fro

HLA-DR expression is associated with bet
HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers
✍ Michael D. Walsh; Owen F. Dent; Joanne P. Young; Caroline M. Wright; Melissa A. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 226 KB

## Abstract Predicting patient outcome for colorectal carcinoma (CRC) with lymph node but not distant metastases remains challenging. Various prognostic markers have been identified including microsatellite instability (MSI) and possibly expression of the MHC Class II protein, HLA‐DR. About 15% of

Hla type and survival in lung cancer
Hla type and survival in lung cancer
✍ Gary B. Weiss; Lynn B. Nawrocki; Jerry C. Daniels πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 255 KB πŸ‘ 1 views

A significant positive association between antigens HLA Awl9 andlor HLA B5 and a disease-free survival time of one year for patients with lung cancer has been reported but not confirmed. We have HLAtyped 20 white patients with non-oat-cell bronchogenic carcinoma who have survived at least a year fro